ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||||||||||||||
1-chloro-2,4-dinitrobenzene
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 |
|
decreases expression | EXP | 17 | 67,074,847 | 67,138,015 | RGD:6480464 | CTD | |
| G | ABHD10 | abhydrolase domain containing 10 |
|
decreases expression | EXP | 3 | 111,697,828 | 111,712,210 | RGD:6480464 | CTD | |
| G | ACOX2 | acyl-CoA oxidase 2, branched chain |
|
increases expression | EXP | 3 | 58,490,863 | 58,522,929 | RGD:6480464 | CTD | |
| G | ADAMTS15 | ADAM metallopeptidase with thrombospondin type 1 motif, 15 |
|
increases expression | ISO | 11 | 130,318,869 | 130,346,539 | RGD:6480464 | CTD | |
| G | ADORA2B | adenosine A2b receptor |
|
increases expression | EXP | 17 | 15,848,231 | 15,879,210 | RGD:6480464 | CTD | |
| G | AICDA | activation-induced cytidine deaminase |
|
affects expression | ISO | 12 | 8,754,762 | 8,765,442 | RGD:6480464 | CTD | |
| G | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) |
|
increases expression | EXP | 7 | 134,127,107 | 134,143,888 | RGD:6480464 | CTD | |
| G | AKR1B10 | aldo-keto reductase family 1, member B10 (aldose reductase) |
|
increases expression | EXP | 7 | 134,212,344 | 134,226,166 | RGD:6480464 | CTD | |
| G | AKR1C1 | aldo-keto reductase family 1, member C1 |
|
increases expression | EXP | 10 | 5,005,454 | 5,020,158 | RGD:6480464 | CTD | |
| G | AKR1C2 | aldo-keto reductase family 1, member C2 |
|
increases expression | EXP | 10 | 5,029,967 | 5,060,225 | RGD:6480464 | CTD | |
| G | AKR1C2 | aldo-keto reductase family 1, member C2 |
|
increases activity | EXP | 10 | 5,029,967 | 5,060,225 | RGD:6480464 | CTD | |
| G | AKR1C2 | aldo-keto reductase family 1, member C2 |
|
increases expression | EXP | 10 | 5,029,967 | 5,060,225 | RGD:6480464 | CTD | |
| G | AKR1C3 | aldo-keto reductase family 1, member C3 |
|
increases expression | EXP | 10 | 5,090,958 | 5,149,878 | RGD:6480464 | CTD | |
| G | AKR1C3 | aldo-keto reductase family 1, member C3 |
|
affects expression | ISO | 10 | 5,090,958 | 5,149,878 | RGD:6480464 | CTD | |
| G | ANKRD2 | ankyrin repeat domain 2 (stretch responsive muscle) |
|
increases expression | ISO | 10 | 99,332,256 | 99,343,641 | RGD:6480464 | CTD | |
| G | ANXA1 | annexin A1 |
|
increases expression | EXP | 9 | 75,766,781 | 75,785,307 | RGD:6480464 | CTD | |
| G | ANXA2 | annexin A2 |
|
increases expression | EXP | 15 | 60,639,350 | 60,690,185 | RGD:6480464 | CTD | |
| G | ARG2 | arginase, type II |
|
increases expression | EXP | 14 | 68,086,579 | 68,118,437 | RGD:6480464 | CTD | |
| G | ARL4C | ADP-ribosylation factor-like 4C |
|
increases expression | EXP | 2 | 235,401,685 | 235,405,693 | RGD:6480464 | CTD | |
| G | ASNS | asparagine synthetase (glutamine-hydrolyzing) |
|
increases expression | ISO | 7 | 97,481,429 | 97,501,854 | RGD:6480464 | CTD | |
| G | AZIN1 | antizyme inhibitor 1 |
|
decreases expression | EXP | 8 | 103,838,536 | 103,876,397 | RGD:6480464 | CTD | |
| G | BAMBI | BMP and activin membrane-bound inhibitor homolog (Xenopus laevis) |
|
increases expression | EXP | 10 | 28,966,424 | 28,971,868 | RGD:6480464 | CTD | |
| G | BCLAF1 | BCL2-associated transcription factor 1 |
|
decreases expression | EXP | 6 | 136,578,001 | 136,610,989 | RGD:6480464 | CTD | |
| G | BDNF | brain-derived neurotrophic factor |
|
multiple interactions | ISO | 11 | 27,676,440 | 27,743,605 | RGD:6480464 | CTD | |
| G | BMP6 | bone morphogenetic protein 6 |
|
increases expression | EXP | 6 | 7,727,011 | 7,881,961 | RGD:6480464 | CTD | |
| G | BSPRY | B-box and SPRY domain containing |
|
increases expression | ISO | 9 | 116,111,812 | 116,133,513 | RGD:6480464 | CTD | |
| G | BST2 | bone marrow stromal cell antigen 2 |
|
increases expression | ISO | 19 | 17,513,755 | 17,516,384 | RGD:6480464 | CTD | |
| G | BTG1 | B-cell translocation gene 1, anti-proliferative |
|
increases expression | EXP | 12 | 92,534,054 | 92,539,673 | RGD:6480464 | CTD | |
| G | BUB1 | BUB1 mitotic checkpoint serine/threonine kinase |
|
decreases expression | EXP | 2 | 111,395,409 | 111,435,684 | RGD:6480464 | CTD | |
| G | C12orf4 | chromosome 12 open reading frame 4 |
|
decreases expression | EXP | 12 | 4,596,901 | 4,647,637 | RGD:6480464 | CTD | |
| G | CA2 | carbonic anhydrase II |
|
decreases expression | EXP | 8 | 86,376,131 | 86,393,721 | RGD:6480464 | CTD | |
| G | CALCA | calcitonin-related polypeptide alpha |
|
increases expression | EXP | 11 | 14,988,215 | 14,993,832 | RGD:6480464 | CTD | |
| G | CALCRL | calcitonin receptor-like |
|
increases expression | EXP | 2 | 188,207,846 | 188,313,021 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
increases expression | EXP | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CCL17 | chemokine (C-C motif) ligand 17 |
|
multiple interactions | ISO | 16 | 57,438,679 | 57,449,974 | RGD:6480464 | CTD | |
| G | CCL17 | chemokine (C-C motif) ligand 17 |
|
increases expression | ISO | 16 | 57,438,679 | 57,449,974 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
decreases expression | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
increases secretion | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
decreases secretion | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
increases expression | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
decreases expression | EXP | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
increases expression | ISO | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
increases secretion | ISO | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL3 | chemokine (C-C motif) ligand 3 |
|
increases expression | EXP | 17 | 34,415,602 | 34,417,506 | RGD:6480464 | CTD | |
| G | CCL3 | chemokine (C-C motif) ligand 3 |
|
increases expression | ISO | 17 | 34,415,602 | 34,417,506 | RGD:6480464 | CTD | |
| G | CCL3 | chemokine (C-C motif) ligand 3 |
|
increases expression | EXP | 17 | 34,415,602 | 34,417,506 | RGD:6480464 | CTD | |
| G | CCL4 | chemokine (C-C motif) ligand 4 |
|
increases expression | EXP | 17 | 34,431,220 | 34,433,014 | RGD:6480464 | CTD | |
| G | CCL4 | chemokine (C-C motif) ligand 4 |
|
increases secretion | EXP | 17 | 34,431,220 | 34,433,014 | RGD:6480464 | CTD | |
| G | CCL4 | chemokine (C-C motif) ligand 4 |
|
increases expression | EXP | 17 | 34,431,220 | 34,433,014 | RGD:6480464 | CTD | |
| G | CCL4 | chemokine (C-C motif) ligand 4 |
|
increases expression | EXP | 17 | 34,431,220 | 34,433,014 | RGD:6480464 | CTD | |
| G | CCL4 | chemokine (C-C motif) ligand 4 |
|
increases expression | ISO | 17 | 34,431,220 | 34,433,014 | RGD:6480464 | CTD | |
| G | CCL4 | chemokine (C-C motif) ligand 4 |
|
increases expression | EXP | 17 | 34,431,220 | 34,433,014 | RGD:6480464 | CTD | |
| G | CCL5 | chemokine (C-C motif) ligand 5 |
|
multiple interactions | ISO | 17 | 34,198,495 | 34,207,377 | RGD:6480464 | CTD | |
| G | CCL5 | chemokine (C-C motif) ligand 5 |
|
increases expression | ISO | 17 | 34,198,495 | 34,207,377 | RGD:6480464 | CTD | |
| G | CCL5 | chemokine (C-C motif) ligand 5 |
|
increases secretion | EXP | 17 | 34,198,495 | 34,207,377 | RGD:6480464 | CTD | |
| G | CCL7 | chemokine (C-C motif) ligand 7 |
|
increases expression | ISO | 17 | 32,597,240 | 32,599,256 | RGD:6480464 | CTD | |
| G | CCL7 | chemokine (C-C motif) ligand 7 |
|
increases expression | ISO | 17 | 32,597,240 | 32,599,256 | RGD:6480464 | CTD | |
| G | CCL8 | chemokine (C-C motif) ligand 8 |
|
increases expression | ISO | 17 | 32,646,066 | 32,648,421 | RGD:6480464 | CTD | |
| G | CCNA2 | cyclin A2 |
|
affects expression | ISO | 4 | 122,737,599 | 122,745,088 | RGD:6480464 | CTD | |
| G | CCNB1 | cyclin B1 |
|
affects expression | ISO | 5 | 68,462,837 | 68,474,072 | RGD:6480464 | CTD | |
| G | CCNE2 | cyclin E2 |
|
affects expression | ISO | 8 | 95,892,452 | 95,907,482 | RGD:6480464 | CTD | |
| G | CCNF | cyclin F |
|
increases expression | ISO | 16 | 2,479,395 | 2,508,859 | RGD:6480464 | CTD | |
| G | CCR1 | chemokine (C-C motif) receptor 1 |
|
increases expression | ISO | 3 | 46,243,200 | 46,249,832 | RGD:6480464 | CTD | |
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
decreases expression | EXP | 3 | 46,395,235 | 46,402,413 | RGD:6480464 | CTD | |
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
decreases expression | EXP | 3 | 46,395,235 | 46,402,413 | RGD:6480464 | CTD | |
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
increases expression | EXP | 3 | 46,395,235 | 46,402,413 | RGD:6480464 | CTD | |
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
decreases expression | EXP | 3 | 46,395,235 | 46,402,413 | RGD:6480464 | CTD | |
| G | CCR2 | chemokine (C-C motif) receptor 2 |
|
increases expression | ISO | 3 | 46,395,235 | 46,402,413 | RGD:6480464 | CTD | |
| G | CCR4 | chemokine (C-C motif) receptor 4 |
|
affects expression | ISO | 3 | 32,993,066 | 32,996,403 | RGD:6480464 | CTD | |
| G | CCR5 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
|
increases expression | EXP | 3 | 46,411,633 | 46,417,697 | RGD:6480464 | CTD | |
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
increases expression | ISO | 17 | 38,710,021 | 38,721,736 | RGD:6480464 | CTD | |
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
increases expression | EXP | 17 | 38,710,021 | 38,721,736 | RGD:6480464 | CTD | |
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
increases expression | EXP | 17 | 38,710,021 | 38,721,736 | RGD:6480464 | CTD | |
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
increases expression | EXP | 17 | 38,710,021 | 38,721,736 | RGD:6480464 | CTD | |
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
multiple interactions | EXP | 17 | 38,710,021 | 38,721,736 | RGD:6480464 | CTD | |
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
increases expression | EXP | 17 | 38,710,021 | 38,721,736 | RGD:6480464 | CTD | |
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
decreases expression | EXP | 17 | 38,710,021 | 38,721,736 | RGD:6480464 | CTD | |
| G | CCR7 | chemokine (C-C motif) receptor 7 |
|
increases expression | EXP | 17 | 38,710,021 | 38,721,736 | RGD:6480464 | CTD | |
| G | CD160 | CD160 molecule |
|
affects expression | ISO | 1 | 145,695,798 | 145,715,565 | RGD:6480464 | CTD | |
| G | CD207 | CD207 molecule, langerin |
|
affects expression | ISO | 2 | 71,057,343 | 71,062,953 | RGD:6480464 | CTD | |
| G | CD274 | CD274 molecule |
|
increases expression | EXP | 9 | 5,450,503 | 5,470,567 | RGD:6480464 | CTD | |
| G | CD36 | CD36 molecule (thrombospondin receptor) |
|
decreases expression | EXP | 7 | 80,231,504 | 80,308,593 | RGD:6480464 | CTD | |
| G | CD40 | CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression | EXP | 20 | 44,746,906 | 44,758,384 | RGD:6480464 | CTD | |
| G | CD40 | CD40 molecule, TNF receptor superfamily member 5 |
|
increases expression | EXP | 20 | 44,746,906 | 44,758,384 | RGD:6480464 | CTD | |
| G | CD5L | CD5 molecule-like |
|
affects expression | ISO | 1 | 157,800,704 | 157,811,634 | RGD:6480464 | CTD | |
| G | CD83 | CD83 molecule |
|
affects expression | ISO | 6 | 14,117,487 | 14,137,149 | RGD:6480464 | CTD | |
| G | CD83 | CD83 molecule |
|
increases expression | EXP | 6 | 14,117,487 | 14,137,149 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
multiple interactions | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
multiple interactions | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
multiple interactions | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
multiple interactions | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
multiple interactions | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
multiple interactions | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
increases expression | EXP | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CDC20 | cell division cycle 20 |
|
affects expression | ISO | 1 | 43,824,626 | 43,828,874 | RGD:6480464 | CTD | |
| G | CDC25C | cell division cycle 25C |
|
affects expression | ISO | 5 | 137,620,959 | 137,667,516 | RGD:6480464 | CTD | |
| G | CDCA2 | cell division cycle associated 2 |
|
increases expression | ISO | 8 | 25,316,513 | 25,365,425 | RGD:6480464 | CTD | |
| G | CDH8 | cadherin 8, type 2 |
|
decreases expression | EXP | 16 | 61,685,915 | 62,070,739 | RGD:6480464 | CTD | |
| G | CDK1 | cyclin-dependent kinase 1 |
|
affects expression | ISO | 10 | 62,538,089 | 62,554,610 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression | EXP | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1C | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
|
increases expression | EXP | 11 | 2,904,448 | 2,906,995 | RGD:6480464 | CTD | |
| G | CERKL | ceramide kinase-like |
|
decreases expression | EXP | 2 | 182,401,399 | 182,521,834 | RGD:6480464 | CTD | |
| G | CES1 | carboxylesterase 1 |
|
increases expression | EXP | 16 | 55,836,763 | 55,867,075 | RGD:6480464 | CTD | |
| G | CIDEC | cell death-inducing DFFA-like effector c |
|
increases expression | EXP | 3 | 9,908,394 | 9,921,938 | RGD:6480464 | CTD | |
| G | CISD1 | CDGSH iron sulfur domain 1 |
|
decreases expression | EXP | 10 | 60,028,862 | 60,049,019 | RGD:6480464 | CTD | |
| G | CLIC4 | chloride intracellular channel 4 |
|
increases expression | EXP | 1 | 25,071,760 | 25,170,815 | RGD:6480464 | CTD | |
| G | CMPK2 | cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial |
|
decreases expression | EXP | 2 | 6,980,684 | 7,006,766 | RGD:6480464 | CTD | |
| G | CPNE3 | copine III |
|
decreases expression | EXP | 8 | 87,526,656 | 87,573,726 | RGD:6480464 | CTD | |
| G | CREB1 | cAMP responsive element binding protein 1 |
|
affects expression | EXP | 2 | 208,394,616 | 208,470,284 | RGD:6480464 | CTD | |
| G | CREM | cAMP responsive element modulator |
|
increases expression | EXP | 10 | 35,415,769 | 35,501,886 | RGD:6480464 | CTD | |
| G | CREM | cAMP responsive element modulator |
|
increases expression | EXP | 10 | 35,415,769 | 35,501,886 | RGD:6480464 | CTD | |
| G | CREM | cAMP responsive element modulator |
|
increases expression | EXP | 10 | 35,415,769 | 35,501,886 | RGD:6480464 | CTD | |
| G | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression | ISO | 5 | 131,409,485 | 131,411,863 | RGD:6480464 | CTD | |
| G | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
increases secretion | ISO | 5 | 131,409,485 | 131,411,863 | RGD:6480464 | CTD | |
| G | CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
|
increases expression | ISO | X Y |
1,387,693 1,337,693 |
1,428,828 1,378,828 |
RGD:6480464 | CTD | |
| G | CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
increases expression | ISO | 22 | 37,309,675 | 37,336,481 | RGD:6480464 | CTD | |
| G | CSF3 | colony stimulating factor 3 (granulocyte) |
|
increases expression | ISO | 17 | 38,171,614 | 38,174,066 | RGD:6480464 | CTD | |
| G | CSF3R | colony stimulating factor 3 receptor (granulocyte) |
|
increases expression | ISO | 1 | 36,931,644 | 36,948,915 | RGD:6480464 | CTD | |
| G | CTLA4 | cytotoxic T-lymphocyte-associated protein 4 |
|
affects expression | ISO | 2 | 204,732,511 | 204,738,683 | RGD:6480464 | CTD | |
| G | CTSB | cathepsin B |
|
increases expression | EXP | 8 | 11,700,033 | 11,725,646 | RGD:6480464 | CTD | |
| G | CTSC | cathepsin C |
|
decreases expression | EXP | 11 | 88,026,760 | 88,070,941 | RGD:6480464 | CTD | |
| G | CTSL1 | cathepsin L1 |
|
increases expression | EXP | 9 | 90,340,974 | 90,346,384 | RGD:6480464 | CTD | |
| G | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression | EXP | 4 | 74,735,109 | 74,737,019 | RGD:6480464 | CTD | |
| G | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression | ISO | 4 | 74,735,109 | 74,737,019 | RGD:6480464 | CTD | |
| G | CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression | EXP | 4 | 74,735,109 | 74,737,019 | RGD:6480464 | CTD | |
| G | CXCL10 | chemokine (C-X-C motif) ligand 10 |
|
increases expression | ISO | 4 | 76,942,269 | 76,944,689 | RGD:6480464 | CTD | |
| G | CXCL10 | chemokine (C-X-C motif) ligand 10 |
|
increases expression | EXP | 4 | 76,942,269 | 76,944,689 | RGD:6480464 | CTD | |
| G | CXCL14 | chemokine (C-X-C motif) ligand 14 |
|
increases expression | ISO | 5 | 134,906,369 | 134,914,969 | RGD:6480464 | CTD | |
| G | CXCL2 | chemokine (C-X-C motif) ligand 2 |
|
increases expression | ISO | 4 | 74,962,752 | 74,964,997 | RGD:6480464 | CTD | |
| G | CXCL2 | chemokine (C-X-C motif) ligand 2 |
|
increases expression | ISO | 4 | 74,962,752 | 74,964,997 | RGD:6480464 | CTD | |
| G | CXCL2 | chemokine (C-X-C motif) ligand 2 |
|
increases expression | EXP | 4 | 74,962,752 | 74,964,997 | RGD:6480464 | CTD | |
| G | CXCL5 | chemokine (C-X-C motif) ligand 5 |
|
increases expression | ISO | 4 | 74,861,359 | 74,864,416 | RGD:6480464 | CTD | |
| G | CXCR4 | chemokine (C-X-C motif) receptor 4 |
|
increases expression | EXP | 2 | 136,871,919 | 136,875,725 | RGD:6480464 | CTD | |
| G | CXCR4 | chemokine (C-X-C motif) receptor 4 |
|
decreases expression | EXP | 2 | 136,871,919 | 136,875,725 | RGD:6480464 | CTD | |
| G | CXCR4 | chemokine (C-X-C motif) receptor 4 |
|
increases expression | ISO | 2 | 136,871,919 | 136,875,725 | RGD:6480464 | CTD | |
| G | CXCR4 | chemokine (C-X-C motif) receptor 4 |
|
increases expression | EXP | 2 | 136,871,919 | 136,875,725 | RGD:6480464 | CTD | |
| G | CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
increases expression | EXP | 15 | 75,011,883 | 75,017,877 | RGD:6480464 | CTD | |
| G | CYTIP | cytohesin 1 interacting protein |
|
increases expression | EXP | 2 | 158,271,131 | 158,300,604 | RGD:6480464 | CTD | |
| G | CYTIP | cytohesin 1 interacting protein |
|
increases expression | EXP | 2 | 158,271,131 | 158,300,604 | RGD:6480464 | CTD | |
| G | CYTIP | cytohesin 1 interacting protein |
|
increases expression | EXP | 2 | 158,271,131 | 158,300,604 | RGD:6480464 | CTD | |
| G | DACT1 | dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) |
|
decreases expression | ISO | 14 | 59,100,786 | 59,115,039 | RGD:6480464 | CTD | |
| G | DCTPP1 | dCTP pyrophosphatase 1 |
|
decreases expression | EXP | 16 | 30,435,019 | 30,441,373 | RGD:6480464 | CTD | |
| G | DDIT3 | DNA-damage-inducible transcript 3 |
|
multiple interactions | EXP | 12 | 57,910,371 | 57,914,300 | RGD:6480464 | CTD | |
| G | DDIT3 | DNA-damage-inducible transcript 3 |
|
increases expression | EXP | 12 | 57,910,371 | 57,914,300 | RGD:6480464 | CTD | |
| G | DKC1 | dyskeratosis congenita 1, dyskerin |
|
decreases expression | EXP | X | 153,991,031 | 154,005,964 | RGD:6480464 | CTD | |
| G | DLGAP5 | discs, large (Drosophila) homolog-associated protein 5 |
|
decreases expression | EXP | 14 | 55,614,834 | 55,658,396 | RGD:6480464 | CTD | |
| G | DNAJB6 | DnaJ (Hsp40) homolog, subfamily B, member 6 |
|
increases expression | EXP | 7 | 157,129,710 | 157,210,133 | RGD:6480464 | CTD | |
| G | DPYD | dihydropyrimidine dehydrogenase |
|
decreases expression | EXP | 1 | 97,543,299 | 98,386,615 | RGD:6480464 | CTD | |
| G | DSE | dermatan sulfate epimerase |
|
decreases expression | EXP | 6 | 116,601,283 | 116,759,442 | RGD:6480464 | CTD | |
| G | DUSP1 | dual specificity phosphatase 1 |
|
increases expression | EXP | 5 | 172,195,093 | 172,198,203 | RGD:6480464 | CTD | |
| G | DUSP4 | dual specificity phosphatase 4 |
|
increases expression | ISO | 8 | 29,190,579 | 29,208,267 | RGD:6480464 | CTD | |
| G | DUT | deoxyuridine triphosphatase |
|
increases expression | ISO | 15 | 48,623,621 | 48,635,570 | RGD:6480464 | CTD | |
| G | E2F1 | E2F transcription factor 1 |
|
affects expression | ISO | 20 | 32,263,292 | 32,274,210 | RGD:6480464 | CTD | |
| G | EGF | epidermal growth factor |
|
decreases expression | EXP | 4 | 110,834,040 | 110,934,118 | RGD:6480464 | CTD | |
| G | EGR2 | early growth response 2 |
|
decreases expression | EXP | 10 | 64,571,756 | 64,578,927 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
increases expression | EXP | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | ELAVL1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) |
|
increases expression | EXP | 19 | 8,023,457 | 8,070,529 | RGD:6480464 | CTD | |
| G | EMB | embigin |
|
decreases expression | EXP | 5 | 49,692,031 | 49,737,234 | RGD:6480464 | CTD | |
| G | EMD | emerin |
|
affects expression | EXP | X | 153,607,597 | 153,609,883 | RGD:6480464 | CTD | |
| G | ERCC6L | excision repair cross-complementing rodent repair deficiency, complementation group 6-like |
|
increases expression | ISO | X | 71,424,507 | 71,458,858 | RGD:6480464 | CTD | |
| G | ESR1 | estrogen receptor 1 |
|
affects expression | EXP | 6 | 152,011,631 | 152,424,409 | RGD:6480464 | CTD | |
| G | F13A1 | coagulation factor XIII, A1 polypeptide |
|
decreases expression | EXP | 6 | 6,144,311 | 6,320,924 | RGD:6480464 | CTD | |
| G | FABP1 | fatty acid binding protein 1, liver |
|
decreases expression | ISO | 2 | 88,422,501 | 88,427,650 | RGD:6480464 | CTD | |
| G | FABP7 | fatty acid binding protein 7, brain |
|
affects expression | ISO | 6 | 123,100,646 | 123,105,219 | RGD:6480464 | CTD | |
| G | FBXO9 | F-box protein 9 |
|
decreases expression | EXP | 6 | 52,929,796 | 52,965,671 | RGD:6480464 | CTD | |
| G | FECH | ferrochelatase |
|
increases expression | EXP | 18 | 55,212,073 | 55,253,969 | RGD:6480464 | CTD | |
| G | FFAR2 | free fatty acid receptor 2 |
|
increases expression | ISO | 19 | 35,940,617 | 35,942,669 | RGD:6480464 | CTD | |
| G | FGF9 | fibroblast growth factor 9 (glia-activating factor) |
|
increases expression | EXP | 13 | 22,245,215 | 22,278,640 | RGD:6480464 | CTD | |
| G | FGL2 | fibrinogen-like 2 |
|
decreases expression | EXP | 7 | 76,822,688 | 76,829,150 | RGD:6480464 | CTD | |
| G | FIGF | c-fos induced growth factor (vascular endothelial growth factor D) |
|
increases expression | EXP | X | 15,363,713 | 15,402,535 | RGD:6480464 | CTD | |
| G | FOS | FBJ murine osteosarcoma viral oncogene homolog |
|
increases expression | EXP | 14 | 75,745,481 | 75,748,937 | RGD:6480464 | CTD | |
| G | FOSL2 | FOS-like antigen 2 |
|
increases expression | EXP | 2 | 28,615,779 | 28,637,516 | RGD:6480464 | CTD | |
| G | FTH1 | ferritin, heavy polypeptide 1 |
|
increases expression | EXP | 11 | 61,731,757 | 61,735,132 | RGD:6480464 | CTD | |
| G | FTL | ferritin, light polypeptide |
|
increases expression | EXP | 19 | 49,468,566 | 49,470,136 | RGD:6480464 | CTD | |
| G | FXYD4 | FXYD domain containing ion transport regulator 4 |
|
affects expression | ISO | 10 | 43,867,092 | 43,871,783 | RGD:6480464 | CTD | |
| G | G6PD | glucose-6-phosphate dehydrogenase |
|
increases expression | EXP | X | 153,759,606 | 153,775,787 | RGD:6480464 | CTD | |
| G | GAL3ST1 | galactose-3-O-sulfotransferase 1 |
|
affects expression | EXP | 22 | 30,950,624 | 30,960,876 | RGD:6480464 | CTD | |
| G | GCLC | glutamate-cysteine ligase, catalytic subunit |
|
increases expression | EXP | 6 | 53,362,139 | 53,409,927 | RGD:6480464 | CTD | |
| G | GCLC | glutamate-cysteine ligase, catalytic subunit |
|
increases expression | EXP | 6 | 53,362,139 | 53,409,927 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
increases expression | EXP | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GCLM | glutamate-cysteine ligase, modifier subunit |
|
increases expression | EXP | 1 | 94,352,590 | 94,375,012 | RGD:6480464 | CTD | |
| G | GPNMB | glycoprotein (transmembrane) nmb |
|
increases expression | EXP | 7 | 23,286,316 | 23,314,729 | RGD:6480464 | CTD | |
| G | GPX3 | glutathione peroxidase 3 (plasma) |
|
increases expression | EXP | 5 | 150,399,999 | 150,408,554 | RGD:6480464 | CTD | |
| G | GREM1 | gremlin 1, DAN family BMP antagonist |
|
increases expression | EXP | 15 | 33,010,205 | 33,026,870 | RGD:6480464 | CTD | |
| G | GSK3B | glycogen synthase kinase 3 beta |
|
increases expression | EXP | 3 | 119,540,800 | 119,813,264 | RGD:6480464 | CTD | |
| G | GSR | glutathione reductase |
|
increases expression | EXP | 8 | 30,535,578 | 30,585,486 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
multiple interactions | EXP | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
multiple interactions | EXP | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
multiple interactions | EXP | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
increases metabolic processing | EXP | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA1 | glutathione S-transferase alpha 1 |
|
increases expression | ISO | 6 | 52,656,178 | 52,668,664 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
multiple interactions | ISO | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
increases metabolic processing | EXP | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
decreases metabolic processing | EXP | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA2 | glutathione S-transferase alpha 2 |
|
decreases metabolic processing | EXP | 6 | 52,614,885 | 52,628,361 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
affects binding | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
multiple interactions | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
increases glutathionylation | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA3 | glutathione S-transferase alpha 3 |
|
increases expression | ISO | 6 | 52,761,437 | 52,774,496 | RGD:6480464 | CTD | |
| G | GSTA4 | glutathione S-transferase alpha 4 |
|
multiple interactions | EXP | 6 | 52,842,746 | 52,860,178 | RGD:6480464 | CTD | |
| G | GSTA4 | glutathione S-transferase alpha 4 |
|
affects metabolic processing | ISO | 6 | 52,842,746 | 52,860,178 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
affects metabolic processing | EXP | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
affects metabolic processing | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
affects metabolic processing | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
multiple interactions | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
multiple interactions | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
multiple interactions | ISO | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM1 | glutathione S-transferase mu 1 |
|
affects metabolic processing | EXP | 1 | 110,230,418 | 110,236,367 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
affects metabolic processing | EXP | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
multiple interactions | ISO | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
affects activity | ISO | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
increases expression | ISO | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTM2 | glutathione S-transferase mu 2 (muscle) |
|
multiple interactions | ISO | 1 | 110,210,644 | 110,226,619 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
affects metabolic processing | EXP | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
decreases metabolic processing | EXP | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
increases metabolic processing | EXP | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
increases expression | ISO | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM3 | glutathione S-transferase mu 3 (brain) |
|
affects metabolic processing | ISO | 1 | 110,276,554 | 110,283,660 | RGD:6480464 | CTD | |
| G | GSTM4 | glutathione S-transferase mu 4 |
|
multiple interactions | EXP | 1 | 110,198,698 | 110,208,123 | RGD:6480464 | CTD | |
| G | GSTM4 | glutathione S-transferase mu 4 |
|
affects metabolic processing | ISO | 1 | 110,198,698 | 110,208,123 | RGD:6480464 | CTD | |
| G | GSTM4 | glutathione S-transferase mu 4 |
|
affects metabolic processing | EXP | 1 | 110,198,698 | 110,208,123 | RGD:6480464 | CTD | |
| G | GSTM5 | glutathione S-transferase mu 5 |
|
affects metabolic processing | ISO | 1 | 110,254,864 | 110,260,890 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
affects metabolic processing | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
increases expression | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
affects metabolic processing | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
decreases activity | ISO | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
affects metabolic processing | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTP1 | glutathione S-transferase pi 1 |
|
multiple interactions | EXP | 11 | 67,351,066 | 67,354,124 | RGD:6480464 | CTD | |
| G | GSTT2 | glutathione S-transferase theta 2 |
|
affects metabolic processing | ISO | 22 | 24,322,314 | 24,326,106 | RGD:6480464 | CTD | |
| G | GSTT2 | glutathione S-transferase theta 2 |
|
increases metabolic processing | ISO | 22 | 24,322,314 | 24,326,106 | RGD:6480464 | CTD | |
| G | GSTZ1 | glutathione S-transferase zeta 1 |
|
affects metabolic processing | EXP | 14 | 77,787,230 | 77,797,940 | RGD:6480464 | CTD | |
| G | GTF2B | general transcription factor IIB |
|
increases expression | EXP | 1 | 89,318,321 | 89,357,301 | RGD:6480464 | CTD | |
| G | GYPB | glycophorin B (MNS blood group) |
|
decreases expression | EXP | 4 | 144,917,257 | 144,940,496 | RGD:6480464 | CTD | |
| G | GZMA | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
|
increases expression | ISO | 5 | 54,398,474 | 54,406,080 | RGD:6480464 | CTD | |
| G | GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
increases expression | ISO | 14 | 25,100,160 | 25,103,432 | RGD:6480464 | CTD | |
| G | GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
affects expression | ISO | 14 | 25,100,160 | 25,103,432 | RGD:6480464 | CTD | |
| G | GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
increases expression | ISO | 14 | 25,100,160 | 25,103,432 | RGD:6480464 | CTD | |
| G | GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
increases expression | ISO | 14 | 25,100,160 | 25,103,432 | RGD:6480464 | CTD | |
| G | HEATR5B | HEAT repeat containing 5B |
|
decreases expression | EXP | 2 | 37,208,153 | 37,311,485 | RGD:6480464 | CTD | |
| G | HIPK2 | homeodomain interacting protein kinase 2 |
|
increases expression | EXP | 7 7 |
139,246,316 139,415,730 |
139,342,363 139,477,693 |
RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
multiple interactions | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HMOX1 | heme oxygenase (decycling) 1 |
|
increases expression | EXP | 22 | 35,777,060 | 35,790,207 | RGD:6480464 | CTD | |
| G | HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 |
|
decreases expression | EXP | 2 | 178,077,422 | 178,088,685 | RGD:6480464 | CTD | |
| G | HSPA6 | heat shock 70kDa protein 6 (HSP70B') |
|
increases expression | EXP | 1 | 161,494,036 | 161,496,687 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
increases expression | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
increases expression | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
increases expression | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
increases expression | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
increases expression | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
increases expression | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
multiple interactions | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ICAM1 | intercellular adhesion molecule 1 |
|
increases expression | EXP | 19 | 10,381,517 | 10,397,291 | RGD:6480464 | CTD | |
| G | ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
increases expression | EXP | 2 | 8,822,113 | 8,824,583 | RGD:6480464 | CTD | |
| G | IDI1 | isopentenyl-diphosphate delta isomerase 1 |
|
decreases expression | EXP | 10 | 1,085,963 | 1,095,061 | RGD:6480464 | CTD | |
| G | IER3 | immediate early response 3 |
|
increases expression | EXP | 6 | 30,710,976 | 30,712,327 | RGD:6480464 | CTD | |
| G | IFI27 | interferon, alpha-inducible protein 27 |
|
increases expression | ISO | 14 | 94,577,079 | 94,583,033 | RGD:6480464 | CTD | |
| G | IFI27 | interferon, alpha-inducible protein 27 |
|
increases expression | ISO | 14 | 94,577,079 | 94,583,033 | RGD:6480464 | CTD | |
| G | IFI44L | interferon-induced protein 44-like |
|
increases expression | ISO | 1 | 79,086,088 | 79,111,830 | RGD:6480464 | CTD | |
| G | IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression | ISO | 10 | 91,152,303 | 91,166,244 | RGD:6480464 | CTD | |
| G | IFIT2 | interferon-induced protein with tetratricopeptide repeats 2 |
|
decreases expression | EXP | 10 | 91,061,706 | 91,069,033 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases secretion | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
multiple interactions | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases secretion | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
increases expression | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFNG | interferon, gamma |
|
multiple interactions | ISO | 12 | 68,548,550 | 68,553,521 | RGD:6480464 | CTD | |
| G | IFRD1 | interferon-related developmental regulator 1 |
|
increases expression | EXP | 7 | 112,063,199 | 112,117,258 | RGD:6480464 | CTD | |
| G | IGFBP6 | insulin-like growth factor binding protein 6 |
|
increases expression | EXP | 12 | 53,491,436 | 53,496,128 | RGD:6480464 | CTD | |
| G | IL10 | interleukin 10 |
|
increases expression | ISO | 1 | 206,940,948 | 206,945,839 | RGD:6480464 | CTD | |
| G | IL10RA | interleukin 10 receptor, alpha |
|
increases expression | ISO | 11 | 117,857,106 | 117,872,198 | RGD:6480464 | CTD | |
| G | IL11 | interleukin 11 |
|
increases expression | ISO | 19 | 55,875,750 | 55,881,831 | RGD:6480464 | CTD | |
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
increases expression | ISO | 5 | 158,741,791 | 158,757,481 | RGD:6480464 | CTD | |
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
increases expression | ISO | 5 | 158,741,791 | 158,757,481 | RGD:6480464 | CTD | |
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
increases secretion | ISO | 5 | 158,741,791 | 158,757,481 | RGD:6480464 | CTD | |
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
increases expression | ISO | 5 | 158,741,791 | 158,757,481 | RGD:6480464 | CTD | |
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
affects expression | ISO | 5 | 158,741,791 | 158,757,481 | RGD:6480464 | CTD | |
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
increases expression | ISO | 5 | 158,741,791 | 158,757,481 | RGD:6480464 | CTD | |
| G | IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
increases expression | ISO | 5 | 158,741,791 | 158,757,481 | RGD:6480464 | CTD | |
| G | IL12RB1 | interleukin 12 receptor, beta 1 |
|
increases expression | ISO | 19 | 18,170,371 | 18,197,697 | RGD:6480464 | CTD | |
| G | IL13 | interleukin 13 |
|
increases expression | ISO | 5 | 131,993,865 | 131,996,801 | RGD:6480464 | CTD | |
| G | IL13 | interleukin 13 |
|
multiple interactions | ISO | 5 | 131,993,865 | 131,996,801 | RGD:6480464 | CTD | |
| G | IL18 | interleukin 18 (interferon-gamma-inducing factor) |
|
increases activity | ISO | 11 | 112,013,974 | 112,034,840 | RGD:6480464 | CTD | |
| G | IL18 | interleukin 18 (interferon-gamma-inducing factor) |
|
increases expression | ISO | 11 | 112,013,974 | 112,034,840 | RGD:6480464 | CTD | |
| G | IL18R1 | interleukin 18 receptor 1 |
|
increases expression | ISO | 2 | 102,979,097 | 103,015,218 | RGD:6480464 | CTD | |
| G | IL19 | interleukin 19 |
|
increases expression | ISO | 1 | 206,972,215 | 207,016,326 | RGD:6480464 | CTD | |
| G | IL1A | interleukin 1, alpha |
|
increases expression | ISO | 2 | 113,531,492 | 113,542,971 | RGD:6480464 | CTD | |
| G | IL1A | interleukin 1, alpha |
|
increases activity | ISO | 2 | 113,531,492 | 113,542,971 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
increases expression | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
increases expression | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
increases secretion | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
increases expression | ISO | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
affects expression | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | IL1RL1 | interleukin 1 receptor-like 1 |
|
increases expression | ISO | 2 | 102,927,962 | 102,968,497 | RGD:6480464 | CTD | |
| G | IL1RL1 | interleukin 1 receptor-like 1 |
|
increases expression | EXP | 2 | 102,927,962 | 102,968,497 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
increases expression | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
increases expression | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
increases expression | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
increases expression | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL2 | interleukin 2 |
|
increases secretion | ISO | 4 | 123,372,625 | 123,377,650 | RGD:6480464 | CTD | |
| G | IL21 | interleukin 21 |
|
affects expression | ISO | 4 | 123,533,783 | 123,542,212 | RGD:6480464 | CTD | |
| G | IL24 | interleukin 24 |
|
increases expression | ISO | 1 | 207,070,788 | 207,077,484 | RGD:6480464 | CTD | |
| G | IL2RA | interleukin 2 receptor, alpha |
|
affects expression | ISO | 10 | 6,052,657 | 6,104,333 | RGD:6480464 | CTD | |
| G | IL3 | interleukin 3 (colony-stimulating factor, multiple) |
|
increases expression | ISO | 5 | 131,396,347 | 131,398,896 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
affects expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
increases expression | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4 | interleukin 4 |
|
multiple interactions | ISO | 5 | 132,009,678 | 132,018,370 | RGD:6480464 | CTD | |
| G | IL4R | interleukin 4 receptor |
|
increases expression | ISO | 16 | 27,325,230 | 27,376,099 | RGD:6480464 | CTD | |
| G | IL4R | interleukin 4 receptor |
|
increases expression | ISO | 16 | 27,325,230 | 27,376,099 | RGD:6480464 | CTD | |
| G | IL5 | interleukin 5 (colony-stimulating factor, eosinophil) |
|
increases expression | ISO | 5 | 131,877,136 | 131,879,214 | RGD:6480464 | CTD | |
| G | IL5 | interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions | ISO | 5 | 131,877,136 | 131,879,214 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
multiple interactions | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
increases expression | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
multiple interactions | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
increases expression | EXP | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
increases expression | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL6 | interleukin 6 (interferon, beta 2) |
|
increases secretion | ISO | 7 | 22,766,766 | 22,771,621 | RGD:6480464 | CTD | |
| G | IL7 | interleukin 7 |
|
decreases expression | ISO | 8 | 79,645,007 | 79,717,758 | RGD:6480464 | CTD | |
| G | IL7R | interleukin 7 receptor |
|
increases expression | EXP | 5 | 35,856,977 | 35,879,705 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases secretion | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
multiple interactions | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
multiple interactions | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases secretion | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases secretion | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases stability | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases secretion | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases expression | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
multiple interactions | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | IL8 | interleukin 8 |
|
increases secretion | EXP | 4 | 74,606,223 | 74,609,433 | RGD:6480464 | CTD | |
| G | INHBA | inhibin, beta A |
|
increases expression | ISO | 7 | 41,728,601 | 41,742,706 | RGD:6480464 | CTD | |
| G | IPCEF1 | interaction protein for cytohesin exchange factors 1 |
|
decreases expression | EXP | 6 | 154,475,618 | 154,677,900 | RGD:6480464 | CTD | |
| G | IRF1 | interferon regulatory factor 1 |
|
increases expression | EXP | 5 | 131,817,301 | 131,826,465 | RGD:6480464 | CTD | |
| G | IRG1 | immunoresponsive 1 homolog (mouse) |
|
affects expression | ISO | 13 | 77,522,694 | 77,532,777 | RGD:6480464 | CTD | |
| G | IRG1 | immunoresponsive 1 homolog (mouse) |
|
affects expression | ISO | 13 | 77,522,694 | 77,532,777 | RGD:6480464 | CTD | |
| G | ITGAV | integrin, alpha V |
|
affects expression | ISO | 2 | 187,454,790 | 187,545,628 | RGD:6480464 | CTD | |
| G | JUN | jun proto-oncogene |
|
increases expression | EXP | 1 | 59,246,463 | 59,249,785 | RGD:6480464 | CTD | |
| G | KCNJ2 | potassium inwardly-rectifying channel, subfamily J, member 2 |
|
decreases expression | EXP | 17 | 68,165,676 | 68,176,185 | RGD:6480464 | CTD | |
| G | KEAP1 | kelch-like ECH-associated protein 1 |
|
multiple interactions | EXP | 19 | 10,596,796 | 10,614,054 | RGD:6480464 | CTD | |
| G | KEAP1 | kelch-like ECH-associated protein 1 |
|
affects metabolic processing | ISO | 19 | 10,596,796 | 10,614,054 | RGD:6480464 | CTD | |
| G | KEAP1 | kelch-like ECH-associated protein 1 |
|
increases expression | EXP | 19 | 10,596,796 | 10,614,054 | RGD:6480464 | CTD | |
| G | KIF23 | kinesin family member 23 |
|
decreases expression | EXP | 15 | 69,706,627 | 69,740,764 | RGD:6480464 | CTD | |
| G | KLF6 | Kruppel-like factor 6 |
|
increases expression | EXP | 10 | 3,818,188 | 3,827,473 | RGD:6480464 | CTD | |
| G | KLF6 | Kruppel-like factor 6 |
|
increases expression | EXP | 10 | 3,818,188 | 3,827,473 | RGD:6480464 | CTD | |
| G | KLF6 | Kruppel-like factor 6 |
|
increases expression | EXP | 10 | 3,818,188 | 3,827,473 | RGD:6480464 | CTD | |
| G | LGALS7 | lectin, galactoside-binding, soluble, 7 |
|
affects expression | ISO | 19 | 39,261,608 | 39,264,157 | RGD:6480464 | CTD | |
| G | LTB | lymphotoxin beta (TNF superfamily, member 3) |
|
increases expression | ISO | 6 | 31,548,335 | 31,550,202 | RGD:6480464 | CTD | |
| G | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression | EXP | 22 | 38,597,939 | 38,612,518 | RGD:6480464 | CTD | |
| G | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression | EXP | 22 | 38,597,939 | 38,612,518 | RGD:6480464 | CTD | |
| G | MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) |
|
increases expression | EXP | 22 | 38,597,939 | 38,612,518 | RGD:6480464 | CTD | |
| G | MAFG | v-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian) |
|
increases expression | EXP | 17 | 79,876,145 | 79,885,587 | RGD:6480464 | CTD | |
| G | MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression | EXP | 7 | 1,570,368 | 1,582,679 | RGD:6480464 | CTD | |
| G | MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression | EXP | 7 | 1,570,368 | 1,582,679 | RGD:6480464 | CTD | |
| G | MAFK | v-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian) |
|
increases expression | EXP | 7 | 1,570,368 | 1,582,679 | RGD:6480464 | CTD | |
| G | MAGEF1 | melanoma antigen family F, 1 |
|
decreases expression | EXP | 3 | 184,428,155 | 184,429,836 | RGD:6480464 | CTD | |
| G | MAP3K5 | mitogen-activated protein kinase kinase kinase 5 |
|
increases phosphorylation | EXP | 6 | 136,878,187 | 137,113,656 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
multiple interactions | EXP | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK1 | mitogen-activated protein kinase 1 |
|
decreases phosphorylation | EXP | 22 | 22,113,946 | 22,221,970 | RGD:6480464 | CTD | |
| G | MAPK14 | mitogen-activated protein kinase 14 |
|
increases phosphorylation | EXP | 6 | 35,995,454 | 36,079,013 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
multiple interactions | EXP | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK3 | mitogen-activated protein kinase 3 |
|
decreases phosphorylation | EXP | 16 | 30,125,426 | 30,134,630 | RGD:6480464 | CTD | |
| G | MAPK8 | mitogen-activated protein kinase 8 |
|
increases phosphorylation | EXP | 10 | 49,609,687 | 49,643,183 | RGD:6480464 | CTD | |
| G | MARCKS | myristoylated alanine-rich protein kinase C substrate |
|
increases expression | EXP | 6 | 114,178,527 | 114,184,652 | RGD:6480464 | CTD | |
| G | MCTS1 | malignant T cell amplified sequence 1 |
|
decreases expression | EXP | X | 119,737,744 | 119,755,014 | RGD:6480464 | CTD | |
| G | ME1 | malic enzyme 1, NADP(+)-dependent, cytosolic |
|
increases expression | EXP | 6 | 83,920,108 | 84,140,938 | RGD:6480464 | CTD | |
| G | MGMT | O-6-methylguanine-DNA methyltransferase |
|
affects binding | EXP | 10 | 131,265,454 | 131,565,783 | RGD:6480464 | CTD | |
| G | MGST1 | microsomal glutathione S-transferase 1 |
|
increases expression | EXP | 12 | 16,500,076 | 16,530,123 | RGD:6480464 | CTD | |
| G | MKI67 | antigen identified by monoclonal antibody Ki-67 |
|
affects expression | ISO | 10 | 129,894,923 | 129,924,468 | RGD:6480464 | CTD | |
| G | MMP1 | matrix metallopeptidase 1 (interstitial collagenase) |
|
increases expression | EXP | 11 | 102,660,641 | 102,668,966 | RGD:6480464 | CTD | |
| G | MMP10 | matrix metallopeptidase 10 (stromelysin 2) |
|
affects expression | ISO | 11 | 102,641,233 | 102,651,359 | RGD:6480464 | CTD | |
| G | MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) |
|
increases expression | EXP | 11 | 102,706,528 | 102,714,342 | RGD:6480464 | CTD | |
| G | MPO | myeloperoxidase |
|
multiple interactions | ISO | 17 | 56,347,217 | 56,358,296 | RGD:6480464 | CTD | |
| G | MPO | myeloperoxidase |
|
decreases activity | ISO | 17 | 56,347,217 | 56,358,296 | RGD:6480464 | CTD | |
| G | MPO | myeloperoxidase |
|
decreases expression | EXP | 17 | 56,347,217 | 56,358,296 | RGD:6480464 | CTD | |
| G | MRPL35 | mitochondrial ribosomal protein L35 |
|
decreases expression | EXP | 2 | 86,426,556 | 86,440,477 | RGD:6480464 | CTD | |
| G | MRPS6 | mitochondrial ribosomal protein S6 |
|
decreases expression | EXP | 21 | 35,445,823 | 35,515,334 | RGD:6480464 | CTD | |
| G | MS4A7 | membrane-spanning 4-domains, subfamily A, member 7 |
|
increases expression | EXP | 11 | 60,145,958 | 60,163,427 | RGD:6480464 | CTD | |
| G | MT1X | metallothionein 1X |
|
increases expression | EXP | 16 | 56,716,382 | 56,718,108 | RGD:6480464 | CTD | |
| G | MT2A | metallothionein 2A |
|
increases expression | EXP | 16 | 56,642,478 | 56,643,409 | RGD:6480464 | CTD | |
| G | MX2 | myxovirus (influenza virus) resistance 2 (mouse) |
|
increases expression | ISO | 21 | 42,733,950 | 42,780,869 | RGD:6480464 | CTD | |
| G | MYB | v-myb myeloblastosis viral oncogene homolog (avian) |
|
decreases expression | EXP | 6 | 135,502,453 | 135,540,311 | RGD:6480464 | CTD | |
| G | MYC | v-myc myelocytomatosis viral oncogene homolog (avian) |
|
decreases expression | EXP | 8 | 128,748,315 | 128,753,680 | RGD:6480464 | CTD | |
| G | NAMPT | nicotinamide phosphoribosyltransferase |
|
increases expression | EXP | 7 | 105,888,731 | 105,925,638 | RGD:6480464 | CTD | |
| G | NAMPT | nicotinamide phosphoribosyltransferase |
|
increases expression | EXP | 7 | 105,888,731 | 105,925,638 | RGD:6480464 | CTD | |
| G | NAMPT | nicotinamide phosphoribosyltransferase |
|
increases expression | EXP | 7 | 105,888,731 | 105,925,638 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
affects response to substance | ISO | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFE2L2 | nuclear factor (erythroid-derived 2)-like 2 |
|
increases expression | EXP | 2 | 178,095,031 | 178,129,859 | RGD:6480464 | CTD | |
| G | NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
decreases expression | EXP | 4 | 103,422,486 | 103,538,459 | RGD:6480464 | CTD | |
| G | NINJ1 | ninjurin 1 |
|
increases expression | EXP | 9 | 95,883,771 | 95,896,570 | RGD:6480464 | CTD | |
| G | NINJ1 | ninjurin 1 |
|
increases expression | EXP | 9 | 95,883,771 | 95,896,570 | RGD:6480464 | CTD | |
| G | NINJ1 | ninjurin 1 |
|
increases expression | EXP | 9 | 95,883,771 | 95,896,570 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
increases expression | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NOS2 | nitric oxide synthase 2, inducible |
|
multiple interactions | ISO | 17 | 26,083,792 | 26,127,555 | RGD:6480464 | CTD | |
| G | NPR3 | natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
|
affects expression | EXP | 5 | 32,710,743 | 32,791,830 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions | EXP | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | EXP | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | EXP | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | EXP | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | EXP | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | EXP | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NQO1 | NAD(P)H dehydrogenase, quinone 1 |
|
increases expression | EXP | 16 | 69,743,304 | 69,760,533 | RGD:6480464 | CTD | |
| G | NR0B1 | nuclear receptor subfamily 0, group B, member 1 |
|
increases expression | EXP | X | 30,322,539 | 30,327,495 | RGD:6480464 | CTD | |
| G | NR3C1 | nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
increases expression | EXP | 5 | 142,657,496 | 142,815,077 | RGD:6480464 | CTD | |
| G | NREP | neuronal regeneration related protein |
|
decreases expression | EXP | 5 | 111,065,000 | 111,312,628 | RGD:6480464 | CTD | |
| G | NUP88 | nucleoporin 88kDa |
|
increases expression | EXP | 17 | 5,289,346 | 5,323,059 | RGD:6480464 | CTD | |
| G | OSM | oncostatin M |
|
increases expression | ISO | 22 | 30,658,818 | 30,662,829 | RGD:6480464 | CTD | |
| G | OTUD1 | OTU domain containing 1 |
|
increases expression | EXP | 10 | 23,728,198 | 23,731,310 | RGD:6480464 | CTD | |
| G | PAICS | phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase |
|
decreases expression | EXP | 4 | 57,301,915 | 57,327,534 | RGD:6480464 | CTD | |
| G | PDE4B | phosphodiesterase 4B, cAMP-specific |
|
increases expression | EXP | 1 | 66,258,193 | 66,840,262 | RGD:6480464 | CTD | |
| G | PDE4D | phosphodiesterase 4D, cAMP-specific |
|
increases expression | EXP | 5 | 58,264,865 | 59,783,925 | RGD:6480464 | CTD | |
| G | PF4 | platelet factor 4 |
|
increases expression | ISO | 4 | 74,846,542 | 74,847,841 | RGD:6480464 | CTD | |
| G | PGD | phosphogluconate dehydrogenase |
|
increases expression | EXP | 1 | 10,459,085 | 10,480,201 | RGD:6480464 | CTD | |
| G | PHF11 | PHD finger protein 11 |
|
increases expression | ISO | 13 | 50,069,801 | 50,103,117 | RGD:6480464 | CTD | |
| G | PHLDA1 | pleckstrin homology-like domain, family A, member 1 |
|
increases expression | EXP | 12 | 76,419,227 | 76,425,556 | RGD:6480464 | CTD | |
| G | PICALM | phosphatidylinositol binding clathrin assembly protein |
|
increases expression | EXP | 11 | 85,668,214 | 85,780,923 | RGD:6480464 | CTD | |
| G | PIR | pirin (iron-binding nuclear protein) |
|
increases expression | EXP | X | 15,402,921 | 15,511,711 | RGD:6480464 | CTD | |
| G | PLAT | plasminogen activator, tissue |
|
increases expression | EXP | 8 | 42,032,236 | 42,065,194 | RGD:6480464 | CTD | |
| G | PLIN2 | perilipin 2 |
|
increases expression | EXP | 9 | 19,115,759 | 19,127,604 | RGD:6480464 | CTD | |
| G | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 |
|
increases expression | EXP | 18 | 57,567,192 | 57,571,538 | RGD:6480464 | CTD | |
| G | PPA1 | pyrophosphatase (inorganic) 1 |
|
increases expression | ISO | 10 | 71,962,586 | 71,993,190 | RGD:6480464 | CTD | |
| G | PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) |
|
increases expression | ISO | 4 | 74,852,156 | 74,853,907 | RGD:6480464 | CTD | |
| G | PRDX1 | peroxiredoxin 1 |
|
affects oxidation | EXP | 1 | 45,976,707 | 45,988,562 | RGD:6480464 | CTD | |
| G | PRDX2 | peroxiredoxin 2 |
|
increases oxidation | EXP | 19 | 12,907,634 | 12,912,694 | RGD:6480464 | CTD | |
| G | PRDX3 | peroxiredoxin 3 |
|
increases oxidation | EXP | 10 | 120,927,215 | 120,938,345 | RGD:6480464 | CTD | |
| G | PRDX3 | peroxiredoxin 3 |
|
decreases expression | EXP | 10 | 120,927,215 | 120,938,345 | RGD:6480464 | CTD | |
| G | PSMA5 | proteasome (prosome, macropain) subunit, alpha type, 5 |
|
decreases expression | EXP | 1 | 109,941,653 | 109,969,108 | RGD:6480464 | CTD | |
| G | PTCRA | pre T-cell antigen receptor alpha |
|
affects expression | ISO | 6 | 42,883,727 | 42,893,576 | RGD:6480464 | CTD | |
| G | PTGER3 | prostaglandin E receptor 3 (subtype EP3) |
|
decreases expression | EXP | 1 | 71,318,036 | 71,513,491 | RGD:6480464 | CTD | |
| G | PTGR1 | prostaglandin reductase 1 |
|
increases expression | EXP | 9 | 114,312,002 | 114,362,135 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression | EXP | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
increases expression | EXP | 1 | 186,640,944 | 186,649,559 | RGD:6480464 | CTD | |
| G | PYHIN1 | pyrin and HIN domain family, member 1 |
|
decreases expression | EXP | 1 | 158,901,337 | 158,946,849 | RGD:6480464 | CTD | |
| G | RAB32 | RAB32, member RAS oncogene family |
|
decreases expression | EXP | 6 | 146,864,828 | 146,876,086 | RGD:6480464 | CTD | |
| G | RBM17 | RNA binding motif protein 17 |
|
decreases expression | EXP | 10 | 6,130,949 | 6,159,422 | RGD:6480464 | CTD | |
| G | RBPJ | recombination signal binding protein for immunoglobulin kappa J region |
|
decreases expression | EXP | 4 | 26,321,332 | 26,436,753 | RGD:6480464 | CTD | |
| G | RCC1 | regulator of chromosome condensation 1 |
|
increases expression | ISO | 1 | 28,832,455 | 28,865,708 | RGD:6480464 | CTD | |
| G | RECQL4 | RecQ protein-like 4 |
|
increases expression | ISO | 8 | 145,736,667 | 145,743,210 | RGD:6480464 | CTD | |
| G | RGS1 | regulator of G-protein signaling 1 |
|
increases expression | EXP | 1 | 192,544,857 | 192,549,159 | RGD:6480464 | CTD | |
| G | RGS2 | regulator of G-protein signaling 2, 24kDa |
|
increases expression | EXP | 1 | 192,778,169 | 192,781,407 | RGD:6480464 | CTD | |
| G | RHOC | ras homolog family member C |
|
increases expression | EXP | 1 | 113,243,749 | 113,250,025 | RGD:6480464 | CTD | |
| G | RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
|
decreases expression | ISO | 14 | 21,423,630 | 21,424,594 | RGD:6480464 | CTD | |
| G | RPL27A | ribosomal protein L27a |
|
increases expression | EXP | 11 | 8,703,995 | 8,711,419 | RGD:6480464 | CTD | |
| G | RTP4 | receptor (chemosensory) transporter protein 4 |
|
increases expression | ISO | 3 | 187,086,168 | 187,089,372 | RGD:6480464 | CTD | |
| G | RTP4 | receptor (chemosensory) transporter protein 4 |
|
increases expression | ISO | 3 | 187,086,168 | 187,089,372 | RGD:6480464 | CTD | |
| G | RUNX3 | runt-related transcription factor 3 |
|
increases expression | ISO | 1 | 25,226,002 | 25,291,501 | RGD:6480464 | CTD | |
| G | S100A10 | S100 calcium binding protein A10 |
|
increases expression | EXP | 1 | 151,955,386 | 151,966,714 | RGD:6480464 | CTD | |
| G | S100B | S100 calcium binding protein B |
|
decreases expression | EXP | 21 | 48,018,531 | 48,025,035 | RGD:6480464 | CTD | |
| G | SAT1 | spermidine/spermine N1-acetyltransferase 1 |
|
increases expression | EXP | X | 23,801,275 | 23,804,327 | RGD:6480464 | CTD | |
| G | SDC2 | syndecan 2 |
|
increases expression | EXP | 8 | 97,505,882 | 97,624,037 | RGD:6480464 | CTD | |
| G | SEMA4C | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C |
|
increases expression | EXP | 2 | 97,525,473 | 97,535,735 | RGD:6480464 | CTD | |
| G | SERBP1 | SERPINE1 mRNA binding protein 1 |
|
decreases expression | EXP | 1 | 67,873,493 | 67,896,123 | RGD:6480464 | CTD | |
| G | SI | sucrase-isomaltase (alpha-glucosidase) |
|
increases expression | EXP | 3 | 164,696,686 | 164,796,283 | RGD:6480464 | CTD | |
| G | SLAMF1 | signaling lymphocytic activation molecule family member 1 |
|
decreases expression | EXP | 1 | 160,579,891 | 160,617,081 | RGD:6480464 | CTD | |
| G | SLAMF8 | SLAM family member 8 |
|
decreases expression | EXP | 1 | 159,796,479 | 159,807,282 | RGD:6480464 | CTD | |
| G | SLC16A10 | solute carrier family 16, member 10 (aromatic amino acid transporter) |
|
increases expression | EXP | 6 | 111,408,781 | 111,544,608 | RGD:6480464 | CTD | |
| G | SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
|
increases expression | EXP | 12 | 8,071,824 | 8,088,892 | RGD:6480464 | CTD | |
| G | SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
|
decreases expression | EXP | 12 | 8,071,824 | 8,088,892 | RGD:6480464 | CTD | |
| G | SLC7A5 | solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
increases expression | EXP | 16 | 87,863,629 | 87,903,100 | RGD:6480464 | CTD | |
| G | SLPI | secretory leukocyte peptidase inhibitor |
|
affects expression | ISO | 20 | 43,880,879 | 43,883,206 | RGD:6480464 | CTD | |
| G | SMC1A | structural maintenance of chromosomes 1A |
|
decreases expression | EXP | X | 53,401,070 | 53,449,618 | RGD:6480464 | CTD | |
| G | SNAI1 | snail homolog 1 (Drosophila) |
|
increases expression | EXP | 20 | 48,599,513 | 48,605,423 | RGD:6480464 | CTD | |
| G | SNX9 | sorting nexin 9 |
|
increases expression | EXP | 6 | 158,244,294 | 158,366,109 | RGD:6480464 | CTD | |
| G | SOD1 | superoxide dismutase 1, soluble |
|
increases expression | EXP | 21 | 33,031,935 | 33,041,244 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
increases expression | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD2 | superoxide dismutase 2, mitochondrial |
|
increases expression | EXP | 6 | 160,100,148 | 160,114,353 | RGD:6480464 | CTD | |
| G | SOD3 | superoxide dismutase 3, extracellular |
|
increases expression | EXP | 4 | 24,797,085 | 24,802,467 | RGD:6480464 | CTD | |
| G | SPP1 | secreted phosphoprotein 1 |
|
multiple interactions | ISO | 4 | 88,896,802 | 88,904,563 | RGD:6480464 | CTD | |
| G | SPTA1 | spectrin, alpha, erythrocytic 1 (elliptocytosis 2) |
|
increases expression | EXP | 1 | 158,580,496 | 158,656,506 | RGD:6480464 | CTD | |
| G | SQLE | squalene epoxidase |
|
increases expression | ISO | 8 | 126,010,720 | 126,034,525 | RGD:6480464 | CTD | |
| G | SRP72 | signal recognition particle 72kDa |
|
decreases expression | EXP | 4 | 57,333,762 | 57,369,847 | RGD:6480464 | CTD | |
| G | SRXN1 | sulfiredoxin 1 |
|
increases expression | EXP | 20 | 627,259 | 633,890 | RGD:6480464 | CTD | |
| G | STAT1 | signal transducer and activator of transcription 1, 91kDa |
|
decreases expression | EXP | 2 | 191,833,762 | 191,878,976 | RGD:6480464 | CTD | |
| G | STAT4 | signal transducer and activator of transcription 4 |
|
increases expression | EXP | 2 | 191,894,302 | 192,016,322 | RGD:6480464 | CTD | |
| G | STAT5B | signal transducer and activator of transcription 5B |
|
increases expression | EXP | 17 | 40,351,195 | 40,428,424 | RGD:6480464 | CTD | |
| G | STX11 | syntaxin 11 |
|
increases expression | EXP | 6 | 144,471,654 | 144,513,076 | RGD:6480464 | CTD | |
| G | TFDP1 | transcription factor Dp-1 |
|
increases expression | ISO | 13 | 114,239,003 | 114,295,788 | RGD:6480464 | CTD | |
| G | TFEC | transcription factor EC |
|
increases expression | ISO | 7 | 115,575,202 | 115,670,867 | RGD:6480464 | CTD | |
| G | TGIF1 | TGFB-induced factor homeobox 1 |
|
increases expression | EXP | 18 | 3,412,072 | 3,458,409 | RGD:6480464 | CTD | |
| G | THBS1 | thrombospondin 1 |
|
affects expression | ISO | 15 | 39,873,280 | 39,889,668 | RGD:6480464 | CTD | |
| G | THBS4 | thrombospondin 4 |
|
affects expression | ISO | 5 | 79,331,170 | 79,379,110 | RGD:6480464 | CTD | |
| G | TIMP1 | TIMP metallopeptidase inhibitor 1 |
|
affects expression | ISO | X | 47,441,690 | 47,446,190 | RGD:6480464 | CTD | |
| G | TIMP3 | TIMP metallopeptidase inhibitor 3 |
|
increases expression | EXP | 22 | 33,196,802 | 33,259,028 | RGD:6480464 | CTD | |
| G | TMEM254-AS1 | TMEM254 antisense RNA 1 |
|
affects expression | ISO | 10 | 81,805,989 | 81,838,949 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases secretion | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
affects expression | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases secretion | EXP | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases secretion | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
increases expression | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNF | tumor necrosis factor |
|
multiple interactions | ISO | 6 | 31,543,344 | 31,546,113 | RGD:6480464 | CTD | |
| G | TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 |
|
increases expression | EXP | 6 | 138,188,325 | 138,204,451 | RGD:6480464 | CTD | |
| G | TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 |
|
increases expression | EXP | 2 | 152,214,106 | 152,236,562 | RGD:6480464 | CTD | |
| G | TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A |
|
increases expression | ISO | 16 | 3,070,313 | 3,072,384 | RGD:6480464 | CTD | |
| G | TNFSF14 | tumor necrosis factor (ligand) superfamily, member 14 |
|
increases expression | ISO | 19 | 6,663,148 | 6,670,599 | RGD:6480464 | CTD | |
| G | TREX1 | three prime repair exonuclease 1 |
|
increases expression | ISO | 3 | 48,506,919 | 48,509,044 | RGD:6480464 | CTD | |
| G | TRPM6 | transient receptor potential cation channel, subfamily M, member 6 |
|
affects expression | ISO | 9 | 77,337,411 | 77,503,010 | RGD:6480464 | CTD | |
| G | TSLP | thymic stromal lymphopoietin |
|
increases expression | ISO | 5 | 110,405,778 | 110,413,722 | RGD:6480464 | CTD | |
| G | TXN | thioredoxin |
|
multiple interactions | EXP | 9 | 113,006,092 | 113,018,920 | RGD:6480464 | CTD | |
| G | TXN | thioredoxin |
|
increases expression | ISO | 9 | 113,006,092 | 113,018,920 | RGD:6480464 | CTD | |
| G | TXN2 | thioredoxin 2 |
|
increases expression | EXP | 22 | 36,863,093 | 36,877,687 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases expression | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
multiple interactions | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases expression | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases expression | EXP | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
increases oxidation | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD1 | thioredoxin reductase 1 |
|
multiple interactions | ISO | 12 | 104,609,557 | 104,744,085 | RGD:6480464 | CTD | |
| G | TXNRD2 | thioredoxin reductase 2 |
|
increases expression | EXP | 22 | 19,863,040 | 19,929,359 | RGD:6480464 | CTD | |
| G | UBD | ubiquitin D |
|
increases expression | ISO | 6 | 29,523,389 | 29,527,702 | RGD:6480464 | CTD | |
| G | UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
increases expression | EXP | 2 | 234,600,321 | 234,681,951 | RGD:6480464 | CTD | |
| G | USP18 | ubiquitin specific peptidase 18 |
|
increases expression | ISO | 22 | 18,632,758 | 18,660,164 | RGD:6480464 | CTD | |
| G | VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor |
|
increases expression | EXP | 12 | 48,235,320 | 48,298,814 | RGD:6480464 | CTD | |
| G | ZBP1 | Z-DNA binding protein 1 |
|
increases expression | ISO | 20 | 56,178,902 | 56,195,632 | RGD:6480464 | CTD | |
| G | ZBP1 | Z-DNA binding protein 1 |
|
increases expression | ISO | 20 | 56,178,902 | 56,195,632 | RGD:6480464 | CTD | |
| G | ZBTB17 | zinc finger and BTB domain containing 17 |
|
decreases expression | EXP | 1 | 16,268,364 | 16,302,627 | RGD:6480464 | CTD | |
| G | ZFP36L1 | ZFP36 ring finger protein-like 1 |
|
decreases expression | EXP | 14 | 69,254,372 | 69,262,960 | RGD:6480464 | CTD | |
| G | ZFYVE26 | zinc finger, FYVE domain containing 26 |
|
decreases expression | EXP | 14 | 68,213,237 | 68,283,306 | RGD:6480464 | CTD | |
| G | ZMYM3 | zinc finger, MYM-type 3 |
|
decreases expression | EXP | X | 70,459,474 | 70,475,047 | RGD:6480464 | CTD | |
Term paths to the root
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term